Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

NAPRAZOLE-D

Class 5Status: Abandoned
Trademark Logo
Application Number2486233
Trademark Status
Abandoned
Trademark Class5
Application Date2013-02-27
Proprietor NameNATURAL MEDICAMENTS LTD.
Appropriate OfficeMUMBAI
StateMADHYA PRADESH
Trademark TypeDEVICE
User Details01/07/2008
Agent NameTYAGI CERTIFICATIONS SERVICES PVT. LTD.[250]
Agent Address3/112, LALITA PARK, LAXMI NAGAR, DELHI-92
Goods And Services Details[CLASS : 5] MEDICINES AND PHARMACEUTICAL PREPARATIONS, FOOD SUPPLEMENTS NATURAL MEDICAMENTS LTD

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
NAPRAZOLE-D5Abandoned
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about NAPRAZOLE D.

What is the status of trademark application 2486233?
The current status of trademark application 2486233 for NAPRAZOLE-D is Abandoned.
What is the trademark class of NAPRAZOLE-D?
NAPRAZOLE-D is registered under trademark class 5.
Who is the proprietor of NAPRAZOLE-D?
The proprietor of NAPRAZOLE-D is NATURAL MEDICAMENTS LTD..
When was trademark application 2486233 filed?
Trademark application 2486233 for NAPRAZOLE-D was filed on 2013-02-27.